On November 12th, PW MEDTECH (01358) spent 1.034 million Hong Kong dollars to repurchase 1 million shares.
PwC Holdings Limited (01358) announced on November 12, 2024 that it will spend HK$103.4 million to repurchase its shares.
PW MEDTECH (01358) announced that on November 12, 2024, it will spend 1.034 million Hong Kong dollars to repurchase 1 million shares at a repurchase price of 1.03-1.04 Hong Kong dollars per share.
Related Articles
FUJING HOLDINGS (02497) announces annual results with a net profit of MOP 63.385 million, an increase of 22.47% compared to the previous year.
CH RENEW EN INV (00987) announced its performance for the year 2025, with a net profit attributable to shareholders of HK$194.91 million, representing a year-on-year increase of 18.3%.
C FIN INT INV (00721) intends to "5 and 1" benchmark merged shares.
FUJING HOLDINGS (02497) announces annual results with a net profit of MOP 63.385 million, an increase of 22.47% compared to the previous year.
CH RENEW EN INV (00987) announced its performance for the year 2025, with a net profit attributable to shareholders of HK$194.91 million, representing a year-on-year increase of 18.3%.
C FIN INT INV (00721) intends to "5 and 1" benchmark merged shares.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
